Skip to main content
. 2015 Nov 4;4:672. doi: 10.1186/s40064-015-1476-7

Fig. 2.

Fig. 2

Change in bacterial (a, b E. coli; c, d S. aureus) membrane permeability (assayed by crystal violet uptake) in presence of different concentrations of CTAB (a, c) and polymyxin B (b, d). Percentage of crystal violet uptake was plotted against the concentration (µg/ml) of the treatment

HHS Vulnerability Disclosure